Our data demonstrated that CD10-positive tumors with high Ki67 index were associated with high recurrence rate, while EGFR expression was not predictive for prognosis in ameloblastomas but may render such tumors candidate for the new targeted anti-EGFR treatment modalities. Here, MME is linked to ameloblastoma.